Highlights du congrès 2022 de la Société suisse de médecine interne générale : partie 2 [Highlights of Swiss congress of internal general medicine: part 2]

Details

Ressource 1Request a copy Under embargo until 23/05/2024.
UNIL restricted access
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_909E043828E5
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Highlights du congrès 2022 de la Société suisse de médecine interne générale : partie 2 [Highlights of Swiss congress of internal general medicine: part 2]
Journal
Revue medicale suisse
Author(s)
Cominetti F., De La Harpe R., Noverraz V., Simonin M., Mouraux S.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
23/11/2022
Peer-reviewed
Oui
Volume
18
Number
805
Pages
2201-2205
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Abstract
From June 1 to 3, 2022, Lausanne held the spring congress of the Swiss Society of General Internal Medicine: "Changes and Opportunities". In this article, chief residents in internal medicine at CHUV summarize presentations they attended. Internal general medicine is established in french-speaking Switzerland as a transversal specialty, which is reflected in this synthesis with very varied subjects. In thromboembolic disease, the duration of anticoagulation is now based on risk of recurrence. The thrombotic microangiopathy benefit nowadays from targeted therapy which improve diseases' outcomes. The new anti-viral therapy against SARS-CoV-2 (nirmatrelvir/ritonavir) is associated with numerous drug interactions. Finally, professors from Switzerland and abroad give their advices for scientific writing and academic career initiation.
Keywords
Humans, COVID-19, SARS-CoV-2, Internal Medicine, General Practice, Ethnicity
Pubmed
Create date
06/12/2022 15:49
Last modification date
04/10/2023 7:13
Usage data